Start Date
May 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
OSI-906 and Pemetrexed
"Pemetrexed will be administered intravenously on day 1 of cycle 1 at a dose of 500 mg/m2 as a 10-minute infusion. Subsequent doses will be defined by tolerability.~OSI-906 will be administered orally twice daily (12 hours apart) at approximately the same times each day on a continuous schedule, beginning on Day 0 of cycle 1."
Winship Cancer Institute of Emory University, Atlanta
Collaborators (1)
OSI Pharmaceuticals
INDUSTRY
Emory University
OTHER